1932593-75-3Relevant academic research and scientific papers
ROR [gamma]t inhibitor, preparation method and application thereof
-
Paragraph 0417; 0421-0423, (2021/07/08)
The invention relates to the technical field of medicines, in particular to an ROR [gamma]t inhibitor, a preparation method and application thereof. The invention also relates to a pharmaceutical composition containing the compound, a method for preparing the pharmaceutical composition, and application of the compound or the pharmaceutical composition in treatment or prevention of ROR [gamma]t-mediated cancers, inflammations or autoimmune diseases of mammals, especially human beings.
INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR AND USE THEREOF
-
Paragraph 0124; 0127; 0128, (2019/07/23)
Provided are an irreversible inhibitor of a fibroblast growth factor receptor (FGFR) as indicated by formula I, a pharmaceutically acceptable salt, a stereoisomer, a pharmaceutical preparation, a pharmaceutical composition and an application thereof. R1, R2, R3, R4, ring A, Ar, ring B and warhead are as defined in the specification. The compound has high-efficiency and high-selectivity inhibition of a fibroblast growth factor receptor and can be applied to treatment of abnormal FGF/FGFR-mediated diseases, in particular the treatment of cancers.
SULFONAMIDE COMPOUNDS HAVING TNAP INHIBITORY ACTIVITY
-
Page/Page column 225; 226, (2018/07/29)
The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formula (I) or a pharmacologically acceptable salt thereof.
CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS
-
Page/Page column 126; 127, (2013/10/08)
The conformationally restricted, spatially defined macrocyclic ring system of formula (I) is constituted by three distinct molecular parts: Template A, conformation Modulator B and Bridge C. Macrocycles described by this ring system I are readily manufactured by parallel synthesis or combinatorial chemistry in solution or on solid phase. They are designed to interact with a variety of specific biological target classes, examples being agonistic or antagonistic activity on G-protein coupled receptors (GPCRs), inhibitory activity on enzymes or antimicrobial activity. In particular, these macrocycles show inhibitory activity on endothelin converting enzyme of subtype 1 (ECE-1 ) and/or the cysteine protease cathepsin S (CatS), and/or act as antagonists of the oxytocin (OT) receptor, thyrotropin-releasing hormone (TRH) receptor and/or leukotriene B4 (LTB4) receptor, and/or as agonists of the bombesin 3 (BB3) receptor, and/or show antimicrobial activity against at least one bacterial strain. Thus they are showing great potential as medicaments for a variety of diseases.
O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TBTU): A new reagent for the cleavage of tetrahydropyranyl, silyl and 4,4'- dimethoxytrityl ethers
Ramasamy, Kanda S.,Averett, Devron
, p. 709 - 712 (2007/10/03)
A new reagent for the cleavage of tetrahydropyranyl, silyl and 4,4'- dimethoxytrityl ethers is described.
A simple and convenient method for the deprotection of tetrahydropyranyl ether using iodine in methanol
Ramasamy, Kanda S.,Bandaru, Rajanikanth,Averett, Devron
, p. 2881 - 2894 (2007/10/03)
A simple and efficient method for the deprotection of tetrahydropyranyl and 4,4'-dimethoxytrityl ethers using iodine in methanol is described.
